angiotensin ii has been researched along with Acute Confusional Senile Dementia in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (8.11) | 29.6817 |
| 2010's | 20 (54.05) | 24.3611 |
| 2020's | 14 (37.84) | 2.80 |
| Authors | Studies |
|---|---|
| Abadir, PM; Bennett, DA; Cosarderelioglu, C; Dincer, P; Ferrucci, L; George, CJ; Marx-Rattner, R; Nidadavolu, LS; Oh, ES; Powell, L; Salib, J; Tian, J; Walston, JD; Xue, QL | 1 |
| Calus, E; De Deyn, PP; De Meyer, GRY; Hendrickx, JO; Van Dam, D | 1 |
| Kehoe, PG; MacLachlan, R; Miners, JS | 1 |
| Abu Bakar, ZH; Hamezah, HS; Matsuzaki Tada, A; Pahrudin Arrozi, A; Tooyama, I; Yanagisawa, D | 1 |
| Adesuyan, M; Alsugeir, D; Brauer, R; Cheung, ECL; Chui, CSL; Howard, R; Jani, YH; Wong, ICK | 1 |
| Bress, AP; Gabriel, N; Hernandez, I; Marcum, ZA | 1 |
| Chatterjee, B; Fadnavis, M; Kuber, B | 1 |
| Girouard, H; Vallerand, D; Youwakim, J | 1 |
| Chaturvedi, S; Gupta, S; Hanif, K; Mishra, A; Shukla, S; Singh, J; Singh, S; Tiwari, P; Tiwari, V; Wahajuddin, M | 1 |
| Dey, S; Gopi, HN; Nalawade, SA; Pahan, S; Puneeth Kumar, DR; Raghothama, S; Roy, S; Senapati, DK; Singh, M; Toraskar, SU | 1 |
| Hamel, E; Martinot, P; Royea, J | 1 |
| Lesage, F; Li, B; Lu, X; Moeini, M; Thorin, É | 1 |
| Hamel, E; Royea, J | 1 |
| Alatawi, Y; Alghamdi, BS; Alshehri, FS; Balabagno, AO; Chen, Y; Durmanova, V; Evangelista, LS; Hromadka, T; Javor, J; Ji, Q; Jiao, J; Kralova, M; Kurdi, M; Labban, S; Li, X; Li, Y; Lv, Q; Minarik, G; Ocenasova, A; Pagsibigan, JS; Parnicka, Z; Reznakova, V; Shawkatova, I; Shen, ZJ; Tian, X; Tu, S; Tuazon, JA; Vaseckova, B; Wang, XY; Wang, Z; Xue, Y; Zeng, LX; Zhang, S; Zhang, ZH; Zuo, C | 1 |
| Ghasemnejad-Berenji, M; Khezri, MR | 1 |
| Cao, C; Hasegawa, Y; Kim-Mitsuyama, S; Koibuchi, N; Lin, B; Takane, K; Yokoo, T | 1 |
| He, T; Katusic, ZS; Pan, Y; Sun, R | 1 |
| Cooper, HA; Eguchi, S; Rizzo, V; Scalia, R | 1 |
| Cao, C; Hasegawa, Y; Hayashi, K; Kim-Mitsuyama, S; Takemoto, Y | 1 |
| Lin, X; Lu, J; Shi, J; Tian, M; Wu, L; Zhang, Y | 1 |
| AbdAlla, S; Fu, X; Langer, A; Quitterer, U | 1 |
| Harding, JW; Kawas, LH; Wright, JW | 1 |
| Bloch, S; Girouard, H; Obari, D | 1 |
| Anrather, J; Faraco, G; Iadecola, C; Luo, W; Park, L; Paul, SM; Zhou, P | 1 |
| Kami, A; Komano, H; Liu, J; Liu, S; Maeda, T; Matsumoto, Y; Michikawa, M; Murakami, S; Sugakawa, Y; Tanabe, C; Zou, K | 1 |
| Capone, C; Claassen, JA; Heerschap, A; Kiliaan, AJ; Mellendijk, L; Wiesmann, M; Zerbi, V | 1 |
| Cribbs, DH; Gillen, DL; Kilday, K; Passos, GF; Vasilevko, V | 1 |
| Claassen, JA; Heerschap, A; Kiliaan, AJ; Roelofs, M; van der Lugt, R; Wiesmann, M | 1 |
| Ashpole, NM; Ballabh, P; Csiszar, A; Gautam, T; Giles, CB; Sonntag, WE; Tarantini, S; Toth, P; Tucsek, Z; Ungvari, Z; Valcarcel-Ares, MN; Wei, JY; Wren, JD | 1 |
| Al Mulhim, N; Kehoe, PG; Miners, JS; Palmer, LE; Wong, S | 1 |
| Hallberg, M | 1 |
| Chrissobolis, S; Drummond, GR; Kemp-Harper, BK; Miller, AA; Sobey, CG | 1 |
| Chen, Z; Liu, W; Shi, J; Tong, Q; Wang, B; Zhang, Y; Zhu, D | 1 |
| Albiston, AL; Ascher, DB; Chai, SY; Cherny, RA; Cromer, BA; Morton, CJ; Parker, MW; Volitakis, I | 1 |
| Shi, J; Tian, M; Xie, W; Zhu, D | 1 |
| Diener, HC; Lüders, S; Schrader, J | 1 |
| Albiston, AL; Chai, SY; Fernando, R; Peck, GR; Ye, S | 1 |
9 review(s) available for angiotensin ii and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Antihypertensive Agents and Incident Alzheimer's Disease: A Systematic Review and Meta-Analysis of Observational Studies.
Topics: Alzheimer Disease; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Humans; Hypertension | 2022 |
Role of angiotensin receptor blockers in the context of Alzheimer's disease.
Topics: Alzheimer Disease; Angiotensin II; Angiotensin Receptor Antagonists; Humans; Hypertension; Receptor, Angiotensin, Type 1 | 2023 |
Brain angiotensin II and angiotensin IV receptors as potential Alzheimer's disease therapeutic targets.
Topics: Aged; Alzheimer Disease; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Brain; Humans; Receptors, Angiotensin; Renin-Angiotensin System | 2020 |
The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases.
Topics: Alzheimer Disease; Angiotensin II; Animals; Humans; Memory Disorders; Parkinson Disease; Receptors, Angiotensin; Renin-Angiotensin System | 2015 |
Angiotensin and neurovascular coupling: beyond hypertension.
Topics: Alzheimer Disease; Angiotensin II; Animals; Disease Models, Animal; Humans; Hypertension; NADPH Oxidases; Neurovascular Coupling; Receptor, Angiotensin, Type 1 | 2015 |
Targeting the insulin-regulated aminopeptidase/AT4 receptor for cognitive disorders.
Topics: Alzheimer Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cognition Disorders; Cystinyl Aminopeptidase; Drug Delivery Systems; Drug Discovery; Humans; Ligands; Models, Biological; Molecular Structure; Receptors, Angiotensin | 2009 |
Oxidative stress and endothelial dysfunction in cerebrovascular disease.
Topics: Alzheimer Disease; Amidohydrolases; Angiotensin II; Animals; Brain Ischemia; Cerebrovascular Disorders; Diabetes Mellitus, Type 2; Disease Models, Animal; Endothelium, Vascular; Humans; Hypertension; Mitochondria; Nitric Oxide; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Prostaglandin-Endoperoxide Synthases; Reperfusion Injury; Stroke; Subarachnoid Hemorrhage; Superoxide Dismutase | 2011 |
[Cerebrovascular sequelae of hypertension].
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Alzheimer Disease; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Dementia, Vascular; Diuretics; Humans; Hypertension; Risk Factors; Stroke; Treatment Outcome | 2003 |
Alzheimer's, angiotensin IV and an aminopeptidase.
Topics: Alzheimer Disease; Aminopeptidases; Angiotensin II; Animals; Binding Sites; Humans | 2004 |
28 other study(ies) available for angiotensin ii and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Higher Angiotensin II Type 1 Receptor Levels and Activity in the Postmortem Brains of Older Persons with Alzheimer's Dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Angiotensin II; Autopsy; Brain; Humans; Receptor, Angiotensin, Type 1 | 2022 |
Short-Term Pharmacological Induction of Arterial Stiffness and Hypertension with Angiotensin II Does Not Affect Learning and Memory and Cerebral Amyloid Load in Two Murine Models of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Amyloidogenic Proteins; Amyloidosis; Angiotensin II; Animals; Cardiovascular Diseases; Disease Models, Animal; Hypertension; Mice; Vascular Stiffness | 2022 |
Dysregulation of ACE-1 in Normal Aging and the Early Stages of Alzheimer's Disease.
Topics: Aging; Alzheimer Disease; Angiotensin II; Humans; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2022 |
Pharmaceutical Potential of Casein-Derived Tripeptide Met-Lys-Pro: Improvement in Cognitive Impairments and Suppression of Inflammation in APP/PS1 Mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Caseins; Cognitive Dysfunction; Disease Models, Animal; Inflammation; Mice; Mice, Inbred C57BL; Mice, Transgenic; NADPH Oxidases; Oligopeptides; Pharmaceutical Preparations; Presenilin-1; Receptors, Angiotensin; Tumor Necrosis Factor-alpha | 2022 |
Association of New Use of Antihypertensives That Stimulate vs Inhibit Type 2 and 4 Angiotensin II Receptors With Dementia Among Medicare Beneficiaries.
Topics: Aged; Alzheimer Disease; Angiotensin II; Antihypertensive Agents; Cohort Studies; Female; Humans; Hypertension; Male; Medicare; United States | 2023 |
Neurovascular Coupling in Hypertension Is Impaired by IL-17A through Oxidative Stress.
Topics: Alzheimer Disease; Angiotensin II; Humans; Hypertension; Interleukin-17; NADPH Oxidases; Neurovascular Coupling; Oxidative Stress; Stroke; Superoxides | 2023 |
ACE2/ANG-(1-7)/Mas receptor axis activation prevents inflammation and improves cognitive functions in streptozotocin induced rat model of Alzheimer's disease-like phenotypes.
Topics: Acetylcholine; Alzheimer Disease; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cognition; Inflammation; Peptide Fragments; Peptidyl-Dipeptidase A; Phenotype; Rats; Reactive Oxygen Species; Receptors, G-Protein-Coupled; Streptozocin | 2023 |
Proteolytically Stable ααγ-Hybrid Peptides Inhibit the Aggregation and Cytotoxicity of Aβ
Topics: Alzheimer Disease; Angiotensin II; Cytoskeleton; Humans; Kinetics; Peptides | 2023 |
Memory and cerebrovascular deficits recovered following angiotensin IV intervention in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Angiotensin II; Animals; Disease Models, Animal; Hippocampus; Humans; Infusions, Intraventricular; Memory; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurovascular Coupling | 2020 |
Hypertension accelerates cerebral tissue PO
Topics: Alzheimer Disease; Angiotensin II; Animals; Cerebral Cortex; Hypertension; Mice; Mice, Transgenic; Oxygen; Partial Pressure; Physical Conditioning, Animal | 2020 |
Topics: Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Angiotensin II; Animals; Antithrombins; Atrial Fibrillation; Body Mass Index; Catheter Ablation; Cohort Studies; Dabigatran; Dogs; Embolism; Factor Xa Inhibitors; Female; Genotype; Hemorrhage; Humans; Hypertension; Hypertrophy, Left Ventricular; Incidence; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 3; Middle Aged; Norepinephrine; Obesity; Polymorphism, Single Nucleotide; Retrospective Studies; Rivaroxaban; Stroke; Sympathectomy | 2017 |
Neurological effects of elevated levels of angiotensin II in COVID-19 patients.
Topics: Alzheimer Disease; Angiotensin II; Angiotensin-Converting Enzyme 2; Blood-Brain Barrier; Cerebral Hemorrhage; COVID-19; Endocytosis; Humans; Permeability; Receptor, Angiotensin, Type 1; SARS-CoV-2 | 2021 |
Detrimental Effects of Centrally Administered Angiotensin II are Enhanced in a Mouse Model of Alzheimer Disease Independently of Blood Pressure.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Angiotensin II; Animals; Behavior, Animal; Blood Pressure; Brain; Cognition; Disease Models, Animal; Hippocampus; Inflammation; Infusions, Intraventricular; Male; Mice; Mice, Transgenic; Muscle, Skeletal; Muscular Atrophy; Oxidative Stress; Sarcopenia; Vasoconstrictor Agents | 2017 |
Effects of senescence and angiotensin II on expression and processing of amyloid precursor protein in human cerebral microvascular endothelial cells.
Topics: Aging; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Angiotensin II; Aspartic Acid Endopeptidases; Blotting, Western; Brain; Cerebral Amyloid Angiopathy; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Humans; Vasoconstrictor Agents | 2018 |
Angiotensin II- and Alzheimer-Type Cardiovascular Aging.
Topics: Age Factors; Aging; Alzheimer Disease; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Autophagy; Brain; Cardiovascular Diseases; Cardiovascular System; Cellular Senescence; Humans; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction; Unfolded Protein Response | 2018 |
Chronic Angiotensin 1-7 Infusion Prevents Angiotensin-II-Induced Cognitive Dysfunction and Skeletal Muscle Injury in a Mouse Model of Alzheimer's Disease.
Topics: Alzheimer Disease; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Body Weight; Cerebrovascular Circulation; Cognitive Dysfunction; Disease Models, Animal; Hippocampus; Maze Learning; Mice; Muscle, Skeletal; Peptide Fragments; Rotarod Performance Test | 2019 |
Angiotensin II triggers autophagy and apoptosis in PC12 cell line: An in vitro Alzheimer's disease model.
Topics: Alzheimer Disease; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Autophagy; Imidazoles; Losartan; Models, Biological; Neurodegenerative Diseases; PC12 Cells; Pyridines; Rats; Receptor, Angiotensin, Type 1 | 2019 |
ACE inhibition with captopril retards the development of signs of neurodegeneration in an animal model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Disease Models, Animal; Hippocampus; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Regeneration; Oligonucleotide Array Sequence Analysis; Oxidation-Reduction; Plaque, Amyloid; Protein Transport; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Transcriptome; Up-Regulation | 2013 |
Hypertension enhances Aβ-induced neurovascular dysfunction, promotes β-secretase activity, and leads to amyloidogenic processing of APP.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Angiotensin II; Animals; Blood Pressure; Cerebral Amyloid Angiopathy; Cerebrovascular Circulation; CHO Cells; Cricetulus; Disease Models, Animal; Hypertension; Male; Mice, Inbred C57BL; Mice, Transgenic | 2016 |
Angiotensin type 1a receptor deficiency decreases amyloid β-protein generation and ameliorates brain amyloid pathology.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Angiotensin II; Animals; Brain; Disease Models, Animal; Mice; Mice, Knockout; Phosphatidylinositol 3-Kinases; Plaque, Amyloid; Protein Aggregation, Pathological; Proto-Oncogene Proteins c-akt; Receptor, Angiotensin, Type 1; Signal Transduction | 2015 |
Hypertension Impairs Cerebral Blood Flow in a Mouse Model for Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Angiotensin II; Animals; Blood Pressure; Cerebral Cortex; Cerebrovascular Circulation; Disease Models, Animal; Essential Hypertension; Hippocampus; Humans; Hypertension; Male; Mice, Inbred C57BL; Mice, Transgenic; Presenilin-1; Thalamus | 2015 |
Experimental hypertension increases spontaneous intracerebral hemorrhages in a mouse model of cerebral amyloidosis.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensin II; Animals; Blood Pressure; Brain; Cerebral Amyloid Angiopathy; Female; Humans; Hypertension; Intracranial Hemorrhage, Hypertensive; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; NG-Nitroarginine Methyl Ester; Risk Factors; Stroke | 2016 |
Angiotensin II, hypertension and angiotensin II receptor antagonism: Roles in the behavioural and brain pathology of a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Behavior, Animal; Blood Pressure; Brain; Cerebrovascular Circulation; Disease Models, Animal; Hypertension; Imidazoles; Maze Learning; Mice, Transgenic; Spatial Learning; Thiophenes | 2017 |
Circulating IGF-1 deficiency exacerbates hypertension-induced microvascular rarefaction in the mouse hippocampus and retrosplenial cortex: implications for cerebromicrovascular and brain aging.
Topics: Aging; Alzheimer Disease; Angiotensin II; Animals; Biomarkers; Blood-Brain Barrier; Cognitive Dysfunction; Gene Expression; Hippocampus; Humans; Hypertension; Insulin-Like Growth Factor I; Male; Mice; Mice, Inbred C57BL; Microvascular Rarefaction; Neocortex; RNA, Messenger | 2016 |
Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Angiotensin I; Angiotensin II; Apolipoproteins E; Autopsy; Brain; Case-Control Studies; Cohort Studies; Female; Humans; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Polymorphism, Single Nucleotide; Statistics as Topic; tau Proteins | 2016 |
Central angiotensin II stimulation promotes β amyloid production in Sprague Dawley rats.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cerebral Ventricles; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Stress, Physiological | 2011 |
Regulation of insulin-regulated membrane aminopeptidase activity by its C-terminal domain.
Topics: Alzheimer Disease; Angiotensin II; Binding Sites; Catalytic Domain; Cystinyl Aminopeptidase; Databases, Protein; Humans; Hydrolysis; Kinetics; Models, Molecular; Molecular Targeted Therapy; Peptide Fragments; Protease Inhibitors; Protein Interaction Domains and Motifs; Protein Structure, Tertiary; Recombinant Proteins; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Zinc | 2011 |
Central angiotensin II-induced Alzheimer-like tau phosphorylation in normal rat brains.
Topics: Alzheimer Disease; Angiotensin II; Animals; Brain; Cognition; Dose-Response Relationship, Drug; Enzyme Activation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Indoles; Losartan; Male; Maleimides; Phosphorylation; Propranolol; Rats; Rats, Sprague-Dawley; Signal Transduction; tau Proteins | 2012 |